In this issue:
Olvi-vec-primed immunochemotherapy promising in PRROC
PRIMA: durable PFS benefit to front-line niraparib maintenance
Treatment and survival of patients with malignant ovarian SCSTs
Surgery essential for malignant ovarian SCSTs
Validation of the Integrated Prediction Model algorithm
Quality of therapy in early ovarian cancer
Textbook outcome as a measure of hospital performances regarding CRS
Missed opportunities for earlier hospice referral in the US
Tumour-first BRCA1/2 testing most effective strategy in patients with EOC
Disparities in clinical trial participation in ovarian cancer
Please login below to download this issue (PDF)